Exelixis Inc. (NASDAQ: EXEL) stock closed at 21.76 per share at the end of the most recent trading day (a -0.55% change compared to the prior day closing price) with a volume of 2.81M shares and market capitalization of 6.93B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 773 people. Exelixis Inc. CEO is Michael M. Morrissey.

The one-year performance of Exelixis Inc. stock is 33.33%, while year-to-date (YTD) performance is 35.66%. EXEL stock has a five-year performance of 23.5%. Its 52-week range is between 14.87 and 22.795, which gives EXEL stock a 52-week price range ratio of 86.94%

Exelixis Inc. currently has a PE ratio of 18.00, a price-to-book (PB) ratio of 2.24, a price-to-sale (PS) ratio of 4.58, a price to cashflow ratio of 14.50, a PEG ratio of 0.87, a ROA of 12.22%, a ROC of 12.19% and a ROE of 14.37%. The company’s profit margin is 17.90%, its EBITDA margin is 23.40%, and its revenue ttm is $1.19 Billion , which makes it $3.68 revenue per share.

Of the last four earnings reports from Exelixis Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.20 for the next earnings report. Exelixis Inc.’s next earnings report date is 07th Nov 2023.

The consensus rating of Wall Street analysts for Exelixis Inc. is Strong Buy (1.39), with a target price of $26.58, which is +22.15% compared to the current price. The earnings rating for Exelixis Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Exelixis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Exelixis Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 6.31, ATR14 : 0.41, CCI20 : 9.16, Chaikin Money Flow : -0.17, MACD : 0.13, Money Flow Index : 49.04, ROC : 0.32, RSI : 51.44, STOCH (14,3) : 47.93, STOCH RSI : 0.00, UO : 46.85, Williams %R : -52.07), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Exelixis Inc. in the last 12-months were: Aftab Dana (Sold 4 600 shares of value $103 362 ), Alan M. Garber (Option Excercise at a value of $252 000), Alan M. Garber (Sold 40 000 shares of value $699 600 ), Dana T. Aftab (Option Excercise at a value of $1 216 049), Dana T. Aftab (Sold 82 500 shares of value $1 443 750 ), Garber Alan (Option Excercise at a value of $252 000), Garber Alan (Sold 40 000 shares of value $699 600 ), George H. Poste (Option Excercise at a value of $252 000), George H. Poste (Sold 40 000 shares of value $667 200 ), Hessekiel Jeffrey (Sold 0 shares of value $-615 985 ), Hessekiel Jeffrey (Sold 116 790 shares of value $2 112 730 ), Jack L. Wyszomierski (Option Excercise at a value of $252 000), Jack L. Wyszomierski (Sold 15 300 shares of value $254 133 ), Jeffrey J. Hessekiel (Option Excercise at a value of $205 328), Jeffrey J. Hessekiel (Sold 38 930 shares of value $778 989 ), Michael M. Morrissey (Option Excercise at a value of $420 000), Morrissey Michael (Option Excercise at a value of $5 931 600), Patrick J. Haley (Option Excercise at a value of $105 000), Patrick J. Haley (Sold 55 553 shares of value $1 065 781 ), Senner Christopher (Option Excercise at a value of $1 768 800), Senner Christopher (Sold 120 000 shares of value $2 471 400 ), Wyszomierski Jack (Option Excercise at a value of $252 000), Wyszomierski Jack (Sold 15 300 shares of value $254 133 )